Skip to main content
Article thumbnail
Location of Repository

Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene

By Kseniya Golovnina, Alexander Blinov, Elena M Akhmametyeva, Leonid V Omelyanchuk and Long-Sheng Chang
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:1315344
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1997). A dual involvement of the amino terminal domain of ezrin in F- and G-actin binding.
    2. (1994). A: Ezrin has a COOH-terminal acting-binding site that is conserved in the ezrin protein family.
    3. (1995). A: Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol Biol Cell
    4. (1999). Activities of the EM10 protein from Echinococcus multilocularis in cultured mammalian cells demonstrate functional relationships to ERM family members. Cell Motil Cytoskeleton
    5. (2001). AI: The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell
    6. (1993). Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature
    7. (1994). Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet
    8. (1994). An exon 8-spliced out transcript of neurofibromatosis 2 gene is constitutively expressed in various human tissues.
    9. (2004). Bioinformatics in reproductive biology – functional annotation based on comparative sequence analysis.
    10. (1991). Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol
    11. (2000). Cox DR: Functional analysis of the neurofibromatosis type 2 protein by means of disease – causing point mutations.
    12. (2001). Crompton MR: Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.
    13. (2004). Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization.
    14. (2002). Derewenda ZS: The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product. Acta Crystollogr Sec D
    15. (1997). DG: The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res
    16. (2004). DH: Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function. Oncogene
    17. (1998). DH: Merlin differentially associates with the microtubule and acting cytoskeleton.
    18. (1994). DL: The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Hum Mol Genet
    19. (2003). Dumanski JP: Strong conservation of the human NF2 locus based on sequence comparison in five species. Mamm Genome
    20. (1998). elegans Sequencing Consortium: Genome sequence of the nematode C. elegans: a platform for investigating biology. Science
    21. (1996). Fehon RG: Distinct cellular and subcellular patterns of expression imply distinct functions for the Drosophila homologues of moesin and the neurofibromatosis 2 tumor suppressor, merlin.
    22. (2002). Fehon RG: ERM proteins and merlin: integrators at the cell cortex. Nature Rev Mol Cell Biol
    23. (1998). Fehon RG: Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization.
    24. (1995). Furthmayr H: Phosphorylation of threonine 558 in the carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets.
    25. (2000). Gadagkar SR: Efficiency of the neighbor-joining method in reconstructing deep and shallow evolutionary relationships in large phylogenies.
    26. (2000). Hakoshima T: Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain.
    27. (2001). Hirbe AC, Haipek CA: Functional analysis of neurofibromatosis 2 (NF2) missense mutations. Hum Mol Genet
    28. (1999). Hoang Lu K: Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations.
    29. (1994). Identification of a cDNA clone from the larval stage of Echinococcus granulosus with homologies to the E. multilocularis antigen EM10-expressing cDNA clone. Parasitol Res
    30. (1993). JF: A novel moezin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell
    31. (2002). JR: p21-activated kinase links Rac/Cdc42 signaling to merlin.
    32. (2000). Karplus PA: Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell
    33. (1998). KB: The FERM domain: a unique module involved in the linkage of the cytoplasmic proteins to the membrane. Trends Biochem Sci
    34. (2004). Krull CE: Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration. Dev Dyn
    35. (1997). Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res
    36. (2004). Merlin and ERM proteins in Schwann cells, neurons and growth cones. Nature Rev Neurosci
    37. (2003). Merlin and ERM proteins: unappreciated roles in cancer development? Nature Rev Cancer
    38. (2002). Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization.
    39. (1994). Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene. Cancer Res
    40. (1994). Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
    41. (2001). Nei M: MEGA2: molecular evolutionary genetics analysis software. Bioinformatics
    42. (1997). Neurofibromatosis 2 gene has novel alternative splicing which control intracellular protein binding.
    43. (2001). NH: The 2.7 Å crystal structure of the activated FERM domain of moesin: an analysis of structural changes on activation. Biochemistry
    44. (1992). NIH Consensus Statement on Acoustic Neuroma: Neurofibromatosis Res. Newsletter
    45. (1999). Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules. Hum Mol Genet
    46. (1997). Olds GR: Identification and molecular cloning of a 67-kilodalton protein in Schistosoma japonicum homologous to a family of actin-binding proteins. Infect Immun
    47. (2004). Phosphorylation of ezrin on threonine T567 plays a crucial role during compaction in the mouse early embryo. Dev Biol
    48. (1998). Phosphorylation of moesin by rho-associated kinase (Rho-kinase) plays a crucial role in the formation of microvilli-like structures.
    49. (2000). Ponta H: CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann NY Acad Sci
    50. (1994). Pulst SM: Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene are conserved and code for schwannomins with distinct C-terminal domains. Hum Mol Genet
    51. (1998). Pulst SM: Neurofibromatosis 2 tumor suppressor schwannomin interacts with βII-spectrin.
    52. (2004). Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression. Oncogene
    53. (2004). Slatko BE: Construction of bacterial artificial chromosome libraries from the parasitic nematode Brugia malayi and physical mapping of the genome of its Wolbachia endosymbiont.
    54. (1998). Structurefunction relationships in the ezrin family and the effect of tumor-associated point mutations in neurofibromatosis 2 protein. Biochim Biophys Acta
    55. (2001). T: Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its Nterminal domain.
    56. (2002). The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins. Science
    57. (2003). The genome sequence of Caenorhabditis briggsae: a platform for comparative genomics. PLoS Biol
    58. (2000). The genome sequence of Drosophila melanogaster. Science
    59. (1994). The murine NF2 homologue encodes a highly conserved merlin protein with alternative forms. Hum Mol Genet
    60. (1987). The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol
    61. (2001). The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev
    62. (1998). Thomas G: Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane. Hum Mol Genet
    63. (1998). Thomas G: NF2 gene in neurofibromatosis type 2 patients. Hum Mol Genet
    64. (1997). Three determinants in ezrin are responsible for cell extension activity. Mol Cell Biol
    65. (2003). Tsukita S, Hakoshima T: Structural basis of adhesion – molecule recognition by ERM proteins revealed by the crystal structure of the radixin – ICAM-2 complex.
    66. (1994). Tsukita S: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeleton.
    67. (1998). Tsukita S: Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moezin (ERM) proteins and regulates their head-to-tail association.
    68. (1994). Tsukita S: Structural diversity of band 4.1 superfamily members.
    69. (2002). Tsukita Sh, Tsukita S, Hakoshima T: Structural basis for neurofibromatosis type2.
    70. (1997). tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
    71. (1995). WD: Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development. Hum Mol Genet
    72. (2002). Welling DB: Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts. Genomics
    73. (2002). WF: Novel syntaxin gene sequences from Giardia, Trypanosoma and algae: implications for the ancient evolution of the eukaryotic endomembrane system.
    74. (1993). Wizardry at the cell cortex. Current Biol
    75. (1992). World Health Org: Prevention and control of neurofibromatosis: Memorandum from a joint WHO/NNFF meeting.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.